Literature DB >> 21947229

Protective effect of andrographolide against concanavalin A-induced liver injury.

Guojun Shi1, Zhijian Zhang, Rong Zhang, Xiaofang Zhang, Yan Lu, Jian Yang, Di Zhang, Zhiguo Zhang, Xiaoying Li, Guang Ning.   

Abstract

This study was designed to investigate the hepatic protective effect and the molecular mechanisms of andrographolide in concanavalin A-induced liver injury model. Results showed that andrographolide (Ag) attenuated concanavalin A (Con-A)-induced liver injury and inhibited hepatocyte apoptosis. Further results showed that oxidative stress response genes were significantly elevated during the pathogenesis induced by Con-A. Meanwhile, gadolinium chloride and N-acetyl-L-cysteine (NAC) treatment, which inactivates Kupffer cells or reduces reactive oxygen species, respectively, prevented the liver injury. So the messenger RNA levels of the oxidative response genes mentioned above were detected, and the following results showed that Ag treatment reduced their expression. Besides, serum lactate dehydrogenase and myeloperoxidase activity was significantly reduced by Ag. Finally, Ag treatment did not further reduce serum tumor necrosis factor-α production compared with NAC treatment alone. Thus, our results indicate that Ag prevents Con-A-induced liver injury and reduced the hepatic oxidative stress response. The hepatic protective effect of Ag indicates that Ag supplementation may be beneficial in the treatment of immune-mediated liver injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947229     DOI: 10.1007/s00210-011-0685-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response.

Authors:  Junghee Lee; Bela Kosaras; Hossein Aleyasin; Jeong A Han; David S Park; Rajiv R Ratan; Neil W Kowall; Robert J Ferrante; Sam W Lee; Hoon Ryu
Journal:  FASEB J       Date:  2006-09-28       Impact factor: 5.191

2.  Andrographolide protects rat hepatocytes against paracetamol-induced damage.

Authors:  P K Visen; B Shukla; G K Patnaik; B N Dhawan
Journal:  J Ethnopharmacol       Date:  1993-10       Impact factor: 4.360

3.  Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.

Authors:  C Loguercio; V De Girolamo; I de Sio; C Tuccillo; A Ascione; F Baldi; G Budillon; L Cimino; A Di Carlo; M P Di Marino; F Morisco; F Picciotto; L Terracciano; R Vecchione; V Verde; C Del Vecchio Blanco
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

4.  Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1.

Authors:  Joydeep Das; Jyotirmoy Ghosh; Prasenjit Manna; Parames C Sil
Journal:  Free Radic Res       Date:  2010-03

5.  Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury.

Authors:  Neha P Trivedi; Upendra M Rawal; Beena P Patel
Journal:  Integr Cancer Ther       Date:  2007-09       Impact factor: 3.279

6.  Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor.

Authors:  F Gantner; M Leist; A W Lohse; P G Germann; G Tiegs
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

7.  Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures.

Authors:  Dumrongsak Pekthong; Nadège Blanchard; Catherine Abadie; Alexandre Bonet; Bruno Heyd; Georges Mantion; Alain Berthelot; Lysiane Richert; Hélène Martin
Journal:  Chem Biol Interact       Date:  2008-11-08       Impact factor: 5.192

8.  Intracellular glutathione regulates Andrographolide-induced cytotoxicity on hepatoma Hep3B cells.

Authors:  Lili Ji; Kaikai Shen; Jun Liu; Ying Chen; Tianyu Liu; Zhengtao Wang
Journal:  Redox Rep       Date:  2009       Impact factor: 4.412

9.  Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.

Authors:  Hiroyuki Nakashima; Manabu Kinoshita; Masahiro Nakashima; Yoshiko Habu; Satoshi Shono; Takefumi Uchida; Nariyoshi Shinomiya; Shuhji Seki
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

10.  Andrographolide inhibits the production of TNF-alpha and interleukin-12 in lipopolysaccharide-stimulated macrophages: role of mitogen-activated protein kinases.

Authors:  Lin-Hua Qin; Ling Kong; Guo-Jun Shi; Zheng-Tao Wang; Bao-Xue Ge
Journal:  Biol Pharm Bull       Date:  2006-02       Impact factor: 2.233

View more
  5 in total

1.  Engineered andrographolide nanoparticles mitigate paracetamol hepatotoxicity in mice.

Authors:  Partha Roy; Suvadra Das; Runa Ghosh Auddy; Achintya Saha; Arup Mukherjee
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

Review 2.  Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells.

Authors:  Florent Duval; Jorge E Moreno-Cuevas; Maria Teresa González-Garza; Carlos Rodríguez-Montalvo; Delia Elva Cruz-Vega
Journal:  Adv Pharmacol Sci       Date:  2014-11-20

Review 3.  The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties.

Authors:  Jinghua Peng
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

4.  Sicyos angulatus ameliorates acute liver injury by inhibiting oxidative stress via upregulation of anti-oxidant enzymes.

Authors:  Hyun-Yong Kim; Jung-Ran Noh; Sung-Je Moon; Dong-Hee Choi; Yong-Hoon Kim; Kyoung-Shim Kim; Hong-Sun Yook; Jin-Pyo An; Won-Keon Oh; Jung Hwan Hwang; Chul-Ho Lee
Journal:  Redox Rep       Date:  2018-12       Impact factor: 4.412

5.  Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent Andrographolide.

Authors:  Thanasekaran Jayakumar; Cheng-Ying Hsieh; Jie-Jen Lee; Joen-Rong Sheu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.